Company Update

Sandu Pharmaceuticals Ltd has announced key board changes approved by shareholders, featuring the redesignation of Shri Balram Viswanathan as Chairman and Managing Director for a three-year term, bringing extensive financial and banking expertise to executive leadership.

Additionally, Dr. Neeti Madan Kapre has been appointed as a Non-Executive Independent Director for a five-year term, adding medical and clinical research credentials to the board.

These leadership updates strengthen corporate governance and strategic oversight, ensuring experienced guidance for the company's future growth and operational management.